More importantly, the patients with high levels of HNRNPC had poor prognosis and correlated with tumor invasion and lymph node metastasis, demonstrating that HNRNPC was a poor prognostic biomarker for NSCLC. This evidence concerns the gene HNRNPC and metastatic malignant neoplasm in the lymph nodes.